Pharma and MedTech
MEDICAL AND SCIENTIFIC LEADERSHIP
Scientific Leadership and Added Value for Patients, Medics and Payers
Our AdBoard-365 concept puts you in a strong position with Key Opinion Leaders.
Continuous scientific collaboration "at eye level", powerful scientific communication and Added Value Programms ensure that your investments into an Advisory Board support the success of your New Products and New Indications.
Epidemiology and Patient Flow Modelling
Epidemiology dynamics and related future Patient Flows play an increasing role in discussions between Pharma companies KOLs and Payers regarding Added Value, Pricing and Reimbursement of new products.
As a consequence, the Medical Affairs function plays an increasing role in generating in-depth insights into the quantitative Patient Flow and impact of New Products and corresponding shifts in treatment algorithms.
Based on numerous epidemiology- & patient flow projects across Europe, we have developed epi2, a platform of tools allowing in-depth quantitative epidemiology- & healthcare system analytics.
The epi2 concept is also based on extensive scientific cooperation with Key Opinion Leaders and other Experts, to allow Pharma Companies to establish and further build Medical Leadership through epidemiology projects.